MedPath

Annex™ Adjacent Level System for Treatment of Adjacent Level Disease

Completed
Conditions
Degenerative Disc Disease
Adjacent Level Disease
Interventions
Device: Annex™ Adjacent Level System
Registration Number
NCT02108249
Lead Sponsor
Spine Wave
Brief Summary

The purpose of this study is to evaluate the clinical, radiological, and surgical outcomes of the Annex™ Adjacent Level System for the treatment of adjacent level disease of the lumbar spine. The Annex™ Adjacent Level System is a spinal fixation system intended to be used with commercially available pedicle screw fixation systems in order to extend existing pedicle screw constructs. Subjects will be evaluated over a 2 year period and compared to historical control.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Men or women 18-85 years of age
  • Single level adjacent level segment disease (ALD) in the lumbar spine (L1-S1).
Exclusion Criteria
  • trauma, tumor, pseudoarthrosis, revision, or same-level recurrent stenosis
  • cervical fusion candidates
  • extraspinal cause of back pain
  • local or systemic infection
  • pregnant / able to become pregnant and not following a reliable contraceptive method
  • Severe osteoporosis or osteopenia
  • Morbid obesity defined as BMI > 40
  • Anatomy or other factors that prohibit safe surgical access to the surgical site
  • Allergy or sensitivity to any component of the treatment procedure
  • Inadequate tissue coverage over the operative site
  • Inadequate bone stock or bone quality
  • Fever or leukocytosis
  • Uncorrectable coagulopathy or hemorrhagic diathesis
  • Cardiopulmonary conditions that present prohibitive anesthesia risk
  • Neuromuscular disease or disorder
  • Mental illness
  • Has an active workman's compensation claim

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Annex GroupAnnex™ Adjacent Level SystemPatients prospectively treated with Annex™ Adjacent Level System
Primary Outcome Measures
NameTimeMethod
Surgical Complication rate compared to retrospective chart reviewWithin 30 days of treatment
% Improvement in Operative/Discharge parameters including surgical time and hospital staywithin 30 days after treatment
Secondary Outcome Measures
NameTimeMethod
% Improvement in Quality of Life using SF-36Up to 2 years post-treatment
% Patient Satisfaction with procedureUp to 2 years post-treatment
% Improvement in Disability using ODIUp to 2 years post-treatment
% Pain reduction on VASUp to 2 years post-treatment

Trial Locations

Locations (1)

Carolinas Neurosurgery and Spine

🇺🇸

Charlotte, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath